Anna Azvolinsky

The higher incidence of bladder cancer in the Northeast in the last 50 years may be attributed to the presence of arsenic in the drinking water, according to a new study.

People who carry a germline breast cancer susceptibility mutation can still substantially lower their risk of developing breast cancer, according to a new study.

The accuracy of interpreting a breast cancer screening mammogram is not diminished as clinicians get toward the end of a session.

Women who do not engage in regular physical activity have an increased risk of developing cervical cancer, according to a new study

Half of all cancer deaths and 20% to 40% of cancer cases in the United States could potentially be prevented if individuals adopted healthier lifestyles, according to a new study.

A team of surgeons performed the first genitourinary reconstructive penile transplant in the United States on a patient whose penis was removed due to a rare form of penile cancer.

The FDA has granted accelerated approval to atezolizumab (Tecentriq) for the treatment of locally advanced or metastatic urothelial carcinoma-the most common type of bladder cancer.

A new study suggests that cholesterol levels rather than cholesterol-lowering statin drugs may actually be responsible for the decrease in colorectal cancer risk.

Regular use of aspirin may reduce the risk of developing cholangiocarcinoma, according to the results of a new study.

Cognitive behavioral therapy may reduce long-term memory-related issues linked to chemotherapy treatment in cancer survivors.

Results of the I-SPY 2 TRIAL found that the neoadjuvant combination of T-DM1 plus pertuzumab resulted in a greater benefit to HER2-positive breast cancer patients compared with paclitaxel plus trastuzumab.

Results of a trial involving a CD4-based immunotherapy has shown activity in patients with metastatic solid tumors, according to phase I data presented at the AACR Annual Meeting.

Prostate cancer patients who kept up a moderate to high level of physical activity had better survival prognoses compared with their more sedentary counterparts.

A new study found that half of women age 40 to 44 evaluated at an academic practice qualified for annual mammography screening for breast cancer.

More than half of women undertreated for their ductal carcinoma in situ may develop a recurrence of the disease or invasive breast cancer within 10 years, according to a study presented at the 2016 American Society of Breast Surgeons Annual Meeting.

A new analysis of the TEXT and SOFT trials examines the absolute effect of exemestane plus ovarian suppression vs tamoxifen across patients with different recurrence risks.

Men who receive pharmacologic androgen deprivation therapy as part of their treatment for prostate cancer may be at higher risk for depression.

While continuing to warn against use of laparoscopic power morcellators for the removal of uterus or uterine fibroids in most women, the FDA is allowing the marketing of a containment system for use with certain power morcellators to isolate tissue not suspected to be cancerous.

Results of a phase II randomized trial found that combining a short course of androgen deprivation therapy with bevacizumab improved relapse-free survival in men with hormone-sensitive prostate cancer.

Using simulation modeling, researchers found that PSA screening can be cost-effective if men with low-risk prostate cancer do not undergo treatment and if clinicians use restrictive criteria to make a decision to biopsy.

The combination of sentinel lymph node mapping and use of uterine intraoperative restrictive frozen section in patients with low-grade endometrial cancer can reduce the rate of complete lymphadenectomy without reducing the detection of lymphatic metastasis.

An ASCO expert panel has endorsed a Cancer Care Ontario guideline on the role of patient and disease factors in the selection of adjuvant therapy for women with early-stage breast cancer.

Combining three markers of homologous recombination deficiency into a single score may improve treatment decisions for women with ovarian cancer, according to a study reported at the 2016 SGO Annual Meeting.

Ultrasound proved better than tomosynthesis at finding breast cancer in women with dense breasts where mammography had not detected any cancer.

Almost 29% of all cancer survivors in the United States have been burdened with financial issues as a result of their diagnosis and treatment.

A quarter of women with HER2-positive breast cancer treated with a combination of lapatinib plus trastuzumab prior to surgery had significant tumor shrinkage within 11 days.

Men who receive radiation therapy as treatment for their prostate cancer may have an increased risk of developing a secondary cancer, according to a meta-analysis of observational studies.

A panel of experts at the ASCO have reviewed and endorsed Cancer Care Ontario’s guideline on Active Surveillance for the Management of Localized Prostate Cancer.

Researchers have uncovered the mechanism that causes about one-third of myeloma cases associated with Gaucher disease, showing that myeloma cells target certain lipids that are elevated in the blood of a subset of patients.

ASCO has published a guideline on biomarker use to guide decisions for adjuvant systemic treatment for women with early-stage, invasive breast cancer.